Takei Hisato, Iizuka Seiichi, Yamamoto Masahiro
Tsumura Kampo Museum, Corporate Communications Dept., TSUMURA & CO., Ibaraki 300-1192, Japan.
Kampo Research and Development Division, TSUMURA & CO., Ibaraki 300-1192, Japan.
Evid Based Complement Alternat Med. 2020 Jun 8;2020:4201508. doi: 10.1155/2020/4201508. eCollection 2020.
Many recent reports have suggested a possible association between Japanese traditional (Kampo) medicines containing Gardeniae Fructus (GF, the fruit of J. Ellis) and the mesenteric phlebosclerosis (MP). MP is a chronic orphan disease characterized by venous calcification extending from the colonic wall to the mesentery, usually developing in the proximal colon. In the present study, we administered GF to Wistar/ST female rats as 1% and 2% feed in the diet for 11 months to evaluate any calcification and/or fibrosis of veins in the colonic wall and mesentery. The reversibility of GF's effects was examined by feeding a normal diet for an additional 3 months. A significant decrease in body weight gain and food consumption occurred in the 2% GF group. Pigmentation of the liver, kidney, and spleen in macroscopic or histopathological examination was observed after 11-month administration, which disappeared after the 3-month recovery period. Histopathological findings such as fibrous thickening and calcification of vein walls, characteristic of human MP, were not observed. Fibrosis in the colonic lamina propria was observed in the 2% GF group but not in the 1% GF group during the treatment period, but the incidence as well as grade of this type of fibrosis decreased in the recovery period, suggesting that the effects of GF were reversible. In the present study, chronic GF administration did not result in any venous pathological changes but induced pigmentation in the liver, kidneys, and spleen and moderate fibrosis in the colonic lamina propria, all of which being reversible. Further studies are required to determine the association between GF and MP.
近期许多报告表明,含栀子(GF,栀子果实)的日本传统(汉方)药物与肠系膜静脉硬化(MP)之间可能存在关联。MP是一种慢性罕见病,其特征为静脉钙化从结肠壁延伸至肠系膜,通常发生在近端结肠。在本研究中,我们以1%和2%的比例将GF添加到Wistar/ST雌性大鼠的饮食中,持续投喂11个月,以评估结肠壁和肠系膜中静脉的钙化和/或纤维化情况。通过额外投喂3个月的正常饮食来检测GF作用的可逆性。2% GF组的体重增加和食物摄入量显著减少。给药11个月后,在大体或组织病理学检查中观察到肝脏、肾脏和脾脏出现色素沉着,在3个月的恢复期后消失。未观察到人类MP特有的静脉壁纤维增厚和钙化等组织病理学表现。在治疗期间,2% GF组观察到结肠固有层纤维化,而1% GF组未观察到,但这种纤维化的发生率和程度在恢复期有所下降,表明GF的作用是可逆的。在本研究中,长期给予GF未导致任何静脉病理变化,但引起肝脏、肾脏和脾脏色素沉着以及结肠固有层中度纤维化,所有这些都是可逆的。需要进一步研究以确定GF与MP之间的关联。